Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$304M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$207M |
| 3 |
Biogen
BIIB
|
+$177M |
| 4 |
MON
Monsanto Co
MON
|
+$164M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$412M |
| 2 |
Pfizer
PFE
|
+$283M |
| 3 |
Devon Energy
DVN
|
+$194M |
| 4 |
Valero Energy
VLO
|
+$187M |
| 5 |
Altria Group
MO
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.04% |
| 2 | Energy | 12.07% |
| 3 | Financials | 9.11% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Industrials | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ATVI
26
DELISTED
Activision Blizzard
ATVI
| $217M | 0.41% |
8,959,404
+4,260,437
| +91% | +$104M |
|
27
PUT
Danaher
DHR
$154B
| $213M | 0.4% |
3,704,702
+3,555,919
| +2,390% | +$204M |
|
28
Expedia Group
EXPE
$38.6B
| $209M | 0.39% |
1,908,272
+516,411
| +37% | +$53.4M |
|
29
Marathon Petroleum
MPC
$101B
| $208M | 0.39% |
3,982,723
-736,609
| -16% | -$37.5M |
|
|
LVLT
30
DELISTED
Level 3 Communications Inc
LVLT
| $201M | 0.38% |
3,820,393
+1,444,166
| +61% | +$79.2M |
|
|
BNY
31
Bank of New York Mellon
BNY
$108B
| $200M | 0.38% |
4,764,618
+3,597,968
| +308% | +$153M |
|
|
SWN
32
DELISTED
Southwestern Energy Company
SWN
| $193M | 0.36% |
8,477,983
+8,057,282
| +1,915% | +$207M |
|
33
Apple
AAPL
$4.51T
| $180M | 0.34% |
5,749,144
-4,582,100
| -44% | -$147M |
|
34
Hartford Financial Services
HIG
$36.9B
| $180M | 0.34% |
4,322,265
+2,773,086
| +179% | +$116M |
|
35
Edwards Lifesciences
EW
$51.8B
| $177M | 0.34% |
7,460,268
+677,742
| +10% | +$15.3M |
|
36
McKesson
MCK
$100B
| $176M | 0.33% |
784,880
-7,566
| -1% | -$1.75M |
|
37
PepsiCo
PEP
$196B
| $173M | 0.33% |
1,854,989
+1,487,280
| +404% | +$142M |
|
38
Pinnacle West Capital
PNW
$11.8B
| $168M | 0.32% |
2,951,216
+1,902,584
| +181% | +$115M |
|
39
Xcel Energy
XEL
$47.7B
| $168M | 0.32% |
5,211,160
-854,937
| -14% | -$28.8M |
|
40
Williams Companies
WMB
$86.2B
| $165M | 0.31% |
2,883,401
+2,277,315
| +376% | +$117M |
|
41
Citigroup
C
$221B
| $164M | 0.31% |
2,970,121
-1,480,401
| -33% | -$80.5M |
|
|
MON
42
DELISTED
Monsanto Co
MON
| $161M | 0.3% |
1,511,818
+1,411,286
| +1,404% | +$164M |
|
43
Ovintiv
OVV
$18.5B
| $159M | 0.3% |
2,888,091
+1,655,714
| +134% | +$105M |
|
44
FirstEnergy
FE
$26.6B
| $157M | 0.3% |
4,833,829
+1,847,149
| +62% | +$64.6M |
|
45
Bank of America
BAC
$431B
| $156M | 0.3% |
9,190,891
-4,371,774
| -32% | -$72M |
|
46
Universal Health Services
UHS
$10.4B
| $156M | 0.3% |
1,099,057
+151,178
| +16% | +$18.9M |
|
|
CXO
47
DELISTED
CONCHO RESOURCES INC.
CXO
| $154M | 0.29% |
1,356,877
+894,034
| +193% | +$108M |
|
|
MNK
48
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $154M | 0.29% |
1,307,247
-259,821
| -17% | -$32M |
|
49
Crown Castle
CCI
$32.1B
| $153M | 0.29% |
1,902,054
+143,401
| +8% | +$12M |
|
|
50
Devon Energy
DVN
$54B
| $151M | 0.29% |
2,536,323
-3,001,883
| -54% | -$194M |
|
Similar funds
Israel Englander's Q2 2015 Portfolio in Review
As of Q2 2015, Israel Englander held 4,294 positions worth $52.9B, down 1.6% from $53.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander's Q2 2015 filing shows 780 new, 1,199 increased, 1,223 reduced and 1,034 closed positions. Its largest new stake was Charter Communications: 575,958 shares worth $98.6M. The largest sale was Teva Pharmaceuticals, an estimated $412M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Energy and Financials.
- Israel Englander's largest Q2 2015 buy was Charter Communications: 575,958 shares worth $98.6M.
- Israel Englander added most to PPL Corp in Q2 2015, an estimated $304M increase.
- Israel Englander's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $412M.
- Israel Englander fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $145M.
- Israel Englander's ten largest holdings make up 11% of its $52.9B portfolio in Q2 2015.
- Israel Englander opened 780 new positions and closed 1,034 in Q2 2015.
- Israel Englander's portfolio value fell 1.6% quarter-over-quarter to $52.9B.
Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.